Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.32 |
| ▸ | RGS12 | O14924 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15739370 | 0.87 | CDC25A (0.34) | ALDH1A1L3MBTL1TDP1 | |
| SCHEMBL17014622 | 0.81 | FAAH (0.33) | MAPK1ALDH1A1MEN1USP2KMT2A | |
| SCHEMBL14702228 | 0.80 | CYP1A2 (0.34) | ALDH1A1MEN1KMT2ATNFPOLB | |
| SCHEMBL14699625 | 0.80 | CYP1A2 (0.34) | ALDH1A1MEN1KMT2ATNFPOLB | |
| SCHEMBL25182939 | 0.80 | CYP3A4 (0.35) | ALDH1A1MEN1KMT2ATNFPOLB | |
| SCHEMBL20658858 | 0.80 | CYP3A4 (0.35) | ALDH1A1MEN1KMT2ATNFPOLB | |
| SCHEMBL15739399 | 0.77 | CDC25A (0.33) | ALDH1A1 | |
| SCHEMBL13858494 | 0.76 | MAPK1 (0.38) | MAPK1ALDH1A1MEN1USP2KMT2A | |
| SCHEMBL15165574 | 0.76 | CYP1A2 (0.32) | TNF | |
| SCHEMBL19418786 | 0.74 | CYP1A2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9502665-B2 | Organic semiconductor material | E.T.C. S.R.L. (IT) | 2016-11-22 | — | — | US | disclosed |
| US-9502665-B2 | Organic semiconductor material | E.T.C. S.R.L. (IT) | 2016-11-22 | — | — | US | disclosed |
| EP-2920184-B1 | ORGANIC SEMICONDUCTOR MATERIAL | E T C SRL (IT) | 2016-09-14 | — | — | EP | disclosed |
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | USINVEST LLC | 2015-08-20 | — | — | US | disclosed |
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | USINVEST LLC | 2015-08-20 | — | — | US | disclosed |
| WO-2014076650-A1 | ORGANIC SEMICONDUCTOR MATERIAL | E.T.C. S.R.L. (IT) | 2014-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | OR10J3, TST, AS3MT | MAPK1 4294/4885ALDH1A1 3257/4885MEN1 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.